Wellcome Trust and MRC invest in world-class Stem Cell Institute
Two of the UK’s largest funders of medical research are to invest £8 million in a new world-leading centre for stem cell biology and medicine.
The Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute will advance our understanding of stem cells and their potential to treat a range of life-threatening conditions that currently have no effective cures.
The new Institute, at the University of Cambridge, will build on existing investment by the Medical Research Council (MRC) and the Wellcome Trust, uniting 30 leading research teams with expertise across the three main types of stem cell: embryonic, adult and induced pluripotent cells.
Research scientists will work alongside technology specialists and doctors to develop new therapeutic approaches underpinned by a strong base of fundamental stem cell biology. Located in Cambridge, the Institute is near the largest cluster of biotechnology companies in Europe, allowing unrivalled opportunities for industry collaboration.
For further information about this investment, please go to the Wellcome Trust news feature.